Supply Chain Intelligence

ProPhase Labs, Inc. Supply Chain

PRPH supply chain intelligence for ProPhase Labs, Inc.: verified suppliers, customers, debt relationships, acquisitions, and ownership data.

PRPH ·Last updated 2026-07-29 · Interactive map →

Data compiled by Redley Lamar · ChainSifter Intelligence

10Suppliers
5Customers
3Debt Items
20Related Chains

ProPhase Labs, Inc. Suppliers

TickerNameConfidenceEvidence
IBO Impact BioMedical Inc. 90% Reciprocal relationship from IBO graph: In exchange, the Licensee shall pay the Company a royalty of 5.5 % of net sales.
STELLA-DIAGNOSTICS-INC STELLA-DIAGNOSTICS-INC 90% On December 15, 2022, we entered into an Asset Purchase Agreement with Stella Diagnostics Inc. and Stella DX, LLC
STELLA-DX-LLC STELLA-DX-LLC 90% On December 15, 2022, we entered into an Asset Purchase Agreement with Stella Diagnostics Inc. and Stella DX, LLC
LIBERTAS-FUNDING-LLC LIBERTAS-FUNDING-LLC 80% On February 14, 2024, the Company entered into an agreement for the sale of future receipts with Libertas Funding, LLC
RDM-CAPITAL-FUNDING RDM-CAPITAL-FUNDING 80% On August 1, 2024, the Company entered into an agreement of sale of future receipts with RDM Capital Funding
STAGE-ADVANCE-LLC STAGE-ADVANCE-LLC 80% On September 29, 2025, the Company entered into an agreement of sale of future receipts with Stage Advance, LLC
DGX Quest Diagnostics Incorporated 72% Reciprocal relationship from DGX graph: Reciprocal relationship from PRPH graph: avorable interpretation of EKRA for laboratory compensation structures, we cannot be assured that courts in our jurisd…
DGX Quest Diagnostics Incorporated 72% avorable interpretation of EKRA for laboratory compensation structures, we cannot be assured that courts in our jurisdiction will reach the same conclusion or that the decision will not be overturned…
IDXG Interpace Biosciences, Inc. 72% COVID-19 and other RPP Molecular tests. Additionally, we compete against regional clinical laboratories providing diagnostic services, including Interpace Biosciences, Inc. The number of companies en…
IDXG Interpace Biosciences, Inc. 72% Reciprocal relationship from IDXG graph: Reciprocal relationship from PRPH graph: Reciprocal relationship from IDXG graph: Reciprocal relationship from PRPH graph: Reciprocal relationship from IDXG g…

ProPhase Labs, Inc. Customers

TickerNameConfidenceEvidence
IBO Impact BioMedical Inc. 80% Reciprocal relationship from IBO graph: Reciprocal relationship from PRPH graph: Reciprocal relationship from IBO graph: License Agreement with ProPhase Labs, Inc. dated March 17, 2022
DGX Quest Diagnostics Incorporated 72% avorable interpretation of EKRA for laboratory compensation structures, we cannot be assured that courts in our jurisdiction will reach the same conclusion or that the decision will not be overturned…
DGX Quest Diagnostics Incorporated 72% Reciprocal relationship from DGX graph: Reciprocal relationship from PRPH graph: Reciprocal relationship from DGX graph: Reciprocal relationship from PRPH graph: Reciprocal relationship from DGX grap…
IDXG Interpace Biosciences, Inc. 72% COVID-19 and other RPP Molecular tests. Additionally, we compete against regional clinical laboratories providing diagnostic services, including Interpace Biosciences, Inc. The number of companies en…
IDXG Interpace Biosciences, Inc. 72% Reciprocal relationship from IDXG graph: Reciprocal relationship from PRPH graph: COVID-19 and other RPP Molecular tests. Additionally, we compete against regional clinical laboratories providing dia…

ProPhase Labs, Inc. Debt Obligations

InstrumentDescriptionConfidenceEvidence
PRPH-DEBT Debt stack $8.6M 90% Market cache reports total debt of $8.6M.
PRPH-DEBT-11899 Warrants outstanding: 7050000 90% xbrl warrant detail from xbrl 2025-09-30.
PRPH-DEBT-11900 Xbrl Convertible 90% xbrl convertible detail from xbrl 2025-09-30.

ProPhase Labs, Inc. Acquisitions

No acquisitions on recordNo completed or pending acquisitions found in our database for ProPhase Labs, Inc..

ProPhase Labs, Inc. Ownership

HolderNameConfidenceEvidence
PRPH-OWNER-BARCLAYS-PLC BARCLAYS PLC 90% 13F overlay lists BARCLAYS PLC as top holder; 2 tracked holders.

ProPhase Labs, Inc. Extended Supply Chain Network

TickerNameChain IndexHopsRelationship Types
CHYM Chime Financial, Inc. 100.00 2
DTIL Precision BioSciences, Inc. 100.00 2
ARMK Aramark 100.00 2
BLX Banco Latinoamericano de Comercio Exterior, S. A. 100.00 2
BMA Banco Macro S.A. 100.00 2
DGX Quest Diagnostics Incorporated 100.00 1 ['customer', 'supplier']
BRBS Blue Ridge Bankshares, Inc. 100.00 2
BTTC Black Titan Corporation 100.00 2
VRNO Verano Holdings Corp. 100.00 2
BSBR Banco Santander (Brasil) S.A. 100.00 2
GEMI Gemini Space Station, Inc. 100.00 2
BRBI BRBI BR Partners S.A. 100.00 2
CNF CNFinance Holdings Limited 100.00 2
BSAC Banco Santander-Chile 100.00 2
AVAL Grupo Aval Acciones y Valores S.A. 100.00 2
BBAR Banco BBVA Argentina S.A. 100.00 2
ENLT Enlight Renewable Energy Ltd 100.00 2
FNWB First Northwest Bancorp 100.00 2
ARM Arm Holdings plc 100.00 2
BCH Banco de Chile 100.00 2
View PRPH supply chain intel →

Explore the full interactive supply chain map for ProPhase Labs, Inc..

Open PRPH supply chain map →
ChainSifter · Guerilla Finance Terms Disclaimer ← Back to Map